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Abstract
Autophagy is an intracellular membrane trafficking pathway controlling the delivery of cytoplasmic material to the
lysosomes for degradation. It plays an important role in cell homeostasis in both normal settings and abnormal,
stressful conditions. It is now recognised that an imbalance in the autophagic process can impact basal cell
functions and this has recently been implicated in several human diseases, including neurodegeneration and
cancer.
Here, we investigated the consequences of nerve injury on the autophagic process in a commonly used model of
neuropathic pain. The expression and modulation of the main autophagic marker, the microtubule-associated
protein 1 light chain 3 (LC3), was evaluated in the L4-L5 cord segment seven days after spinal nerve ligation (SNL).
Levels of LC3-II, the autophagosome-associated LC3 form, were markedly higher in the spinal cord ipsilateral to the
ligation side, appeared to correlate with the upregulation of the calcium channel subunit a2δ-1 and were not
present in mice that underwent sham surgery. However, LC3-I and Beclin 1 expression were only slightly increased.
On the contrary, SNL promoted the accumulation of the ubiquitin- and LC3-binding protein p62, which inversely
correlates with autophagic activity, thus pointing to a block of autophagosome turnover.
Our data showed for the first time that basal autophagy is disrupted in a model of neuropathic pain.
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Background
Neuropathic pain is initiated or caused by a primary
lesion or dysfunction in the nervous system, either per-
ipherally or centrally [1]. It is now clear that pain shares
a lot of similarities with other neurobiological processes
such as learning and memory [2]. However, the partici-
pation of cellular and molecular mechanisms typical of
conditions in which these processes are altered, i.e. in
neurodegenerative diseases, has not received so far ade-
quate attention in respect to the development and main-
tenance of pain states. For instance, the contribution of
spinal neuronal cell death to neuropathic pain has been
investigated in several animal models, but it remains
still controversial. In fact, while apoptosis is reported to
b er e s p o n s i b l ef o rt h es e l e c t i v el o s so fG A B A e r g i ci n h i -
bition in the superficial dorsal horn of the spinal cord
[3], it is questioned whether this cellular loss is neces-
sary for the development of pain behaviour [4]. How-
ever, research so far has focused only on one mode of
cell death, namely apoptosis, without considering other
mechanisms leading to neurodegeneration or to neuro-
nal dysfunction.
Here, we investigated whether degenerative mechan-
isms other than apoptosis may be modulated in a com-
mon experimental model of neuropathic pain. In
particular, we focused on autophagy, a major intracellu-
lar degradation pathway lately implicated in several
pathological conditions and brain diseases [5].
Autophagy is a common cytoprotective mechanism
serving homeostatic functions such as cytoplasmic, pro-
tein and organelles turnover, and providing metabolic
substrates when cell energetic demands are increased
[6]. Basal autophagy is a highly regulated process and an
imbalance in its fine tuning, both towards an increase or
an inhibition, may be detrimental for cell survival. Cellu-
lar autophagic activity is usually low under basal
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ous stimuli. The most known inducer of autophagy is
nutrient starvation, both in cultured cells and in intact
organisms [7]. Autophagy can also be activated by stress
stimuli such as hypoxia, energy depletion, endoplasmic
reticulum stress and hormonal stimulation, by pharma-
cological agents like rapamycin, as well as in bacterial,
viral, and parasitic infections [7]. Conversely, autophagy
suppression is also often associated with a number of
diseases. These include some forms of cancer, neurode-
generative disorders, infectious diseases, and inflamma-
tory bowel disorders [5]. Also, a decline in autophagy
function is a common feature of aging [8].
At least three forms of this process have been identi-
fied–chaperone-mediated autophagy, microautophagy,
and macroautophagy–that differ with respect to their
physiological functions and the mode of cargo delivery
to the lysosome. Macroautophagy (usually referred to as
autophagy) is the major form and consists in the initial
formation of the isolation membrane or phagophore,
which expands and closes around the cytoplasmic cargo
to form a double-membrane autophagosome. This then
fuses with a lysosome to form an autolysosome where
the captured material is degraded together with the
inner membrane [5]. A number of molecules take part
to this dynamic and highly regulated process. Among
these, autophagy-related (Atg) proteins are critical
players. In particular, yeast Atg6, Atg8 and their mam-
malian homologues Beclin 1 and LC3, are required for
the formation of the isolation membrane and the autop-
hagosome [9].
When autophagosome formation is impaired, the sub-
sequent accumulation of damaged organelles and pro-
tein aggregates interferes with cellular functions and
may eventually lead to cell death. In the CNS, these det-
rimental effects are exacerbated by the non-proliferative
nature of neuronal cells and by their specific architec-
ture. In fact, the massive accumulation of defective orga-
nelles and/or protein aggregates resulting from
autophagic failure may disturb axonal traffic and lead to
enhanced neuronal toxicity [10].
Aim of this study was to investigate whether the
autophagic process is altered in the spinal cord follow-
ing spinal nerve injury. The expression of the main
autophagic markers LC3 and Beclin 1 was investigated
in the spinal dorsal horn of adult mice following spinal
nerve ligation (SNL). SNL promoted the appearance of
LC3-II, the autophagosome-associated LC3 form. How-
ever, LC3-I and Beclin 1 expression were not dramati-
cally increased. In contrast, the ubiquitin- and LC3-
binding protein p62 (also known as sequestosome-1/
SQSTM1) was strongly up-regulated, thus pointing
towards a block of autophagosomes turnover in this
experimental model of neuropathic pain.
Results
Spinal nerve ligation induced a severe mechanical
allodynia
Ligation of the spinal nerve L5 produced an early onset
and long lasting mechanical hypersensitivity (Figure 1),
as previously described [11-13]. Tactile hypersensitivity
determined by Von Frey filaments developed 1 day after
SNL (n = 10) and was maintained for up to 28 days
(Figure 1). The same marked decrease in mechanical
thresholds was not observed in the sham group (n = 6;
Figure 1).
Spinal nerve ligation induced LC3 and Beclin 1
modulation
LC3 and Beclin 1 are two key proteins for autophagy
function. Beclin 1 plays a role in the initiation step and
is essential for the formation of the autophagosome
[14]. LC3 exists in two forms. LC3-I is the cytosolic
unconjugated form, which upon conjugation to phos-
phatidylethanolamine is recruited to the autophagosomal
membrane. Due to this lipidation, LC3-I exhibits a
greater electrophoretic mobility and is indicated as LC3-
II. Since LC3-II levels are indicative of the rate of autop-
hagomes formation, one of the most reliable methods to
identify autophagy is the analysis of LC3 expression and
LC3-II formation by Western blotting [14].
We investigated LC3 and Beclin 1 expression by Wes-
tern blot in the cord of mice that underwent either SNL
or sham surgery. Seven days after ligation, the expres-
sion of these autophagic markers was analysed in the
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Figure 1 Spinal nerve ligation induced a severe mechanical
allodynia. A severe and persistent mechanical hypersensitivity
developed and maintained over time following SNL and was absent
in animals that underwent sham surgery. Data were expressed as
mean ± SEM of 50% of pain threshold and were normalized to the
baseline of each animal (sham: n = 6; SNL: n = 10). For all time
points, p < 0.001.
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Page 2 of 8L4-L5 portion of the spinal cord controlateral (C) and
ipsilateral (I) to the ligation.
LC3-I levels were higher in the mice that underwent
L5 ligation than in sham mice (Figure 2A). Also, the
injured side (I) of SNL animals showed a slight increase
in LC3-I levels in comparison to the controlateral side
(Figure 2A and 2B). Moreover, the appearance of LC3-II
w a se v i d e n ti nt h ei n j u r e ds i d eo fS N La n i m a l sb u t
absent in sham mice (Figure 2A and 2C).
Also Beclin 1 expression was higher in animals that
u n d e r w e n tL 5l i g a t i o nt h a ni ns h a mm i c e( F i g u r e3 A ) ,
and a trend towards an increase was observed in the
ipsilateral in comparison to the controlateral side 7 days
after SNL (Figure 3A and 3B).
Given the variability in tissue sampling due to the
small portion of cord taken and to ensure that the
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Figure 2 LC3 expression in the spinal cord following spinal nerve
ligation. (A) LC3 expression was analyzed by Western blot in the
hemi-cord contralateral (C) and ipsilateral (I) to the side of ligation, 7
days after surgery. SNL animals showed higher LC3-I expression than
sham animals (A). A clear trend towards an increased LC3-I expression
in the ipsilateral (I) compared to the contralateral (C) side, together
with the appearance of LC3-II, was observed after ligation (A) and
confirmed by densitometric analysis (B and C). The slight increase in
LC3-I levels and the apparent formation of LC3-II well correlated with
a2δ-1 upregulation (A and D). Signals from each band were
normalized towards the corresponding GADPH signal. One
representative Western blot is shown. Sham: n = 5, SNL: n = 6.
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Figure 3 Beclin 1 expression in the spinal cord following spinal
nerve ligation. (A) Beclin 1 expression was analyzed by Western
blot in the hemi-cord contralateral (C) and ipsilateral (I) to the side
of ligation, 7 days after surgery. SNL animals showed higher Beclin 1
expression than sham animals (A). A clear trend towards an increase
in Beclin 1 expression in the ipsilateral (I) compared to the
contralateral (C) side was observed after ligation (A) and confirmed
by densitometric analysis (B). The slight increase in Beclin 1
expression well correlated with a2δ-1 upregulation (A and C).
Signals from each band were normalized towards the
corresponding GAPDH signal. One representative Western blot is
shown. Sham: n = 5, SNL: n = 6.
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we used the calcium channel subunit a2δ-1 as a refer-
ence for the specific lumbar segment and as a marker
for the neuropathic pain state. Ipsilateral increase of the
a2δ-1 subunit has, indeed, been reported in the dorsal
horn after SNL. This up-regulation starts at about 7
days post surgery and is confined to the cord segment
relative to the injured nerve [15,16].
Variations in both Beclin 1 (Figure 3A) and LC3-I
levels (Figure 2A), as well as LC3-II formation (Figure
2A) well correlated with a2δ-1 upregulation in the
injured side of SNL animals (Figure 2A and 2D, Figure
3A and 3C).
While LC3-I and Beclin 1 showed only a slight
increase following spinal nerve ligation, LC3-II forma-
tion and a2δ-1 upregulation were statistically significant
as shown by statistical analysis of the densitometry data
from 5 SNL mice (*p < 0.05; Figure 4).
p62 upregulation following spinal nerve ligation
LC3 is regarded as a reliable biochemical indicator of
autophagic activity, provided that the autophagy path-
way is fully functioning. In fact, LC3-II accumulation
may also be a consequence of defective autophagosome
clearance rather than increased autophagy.
The ubiquitin-binding protein p62/SQSTM1 is an
autophagy substrate, which upon direct binding to LC3
incorporates into autophagosomes and is efficiently
degraded by autophagy [17,18]. Thus, when autophagy
is blocked, p62 accumulation occurs [19]. To assess the
hypothesis that LC3-II increase was a consequence of
defective autophagosome clearance, we evaluated p62
levels by Western blot in the cord of mice that under-
went either SNL or sham surgery. The expression of
this marker was analysed in the L4-L5 portion of the
spinal cord contralateral (C) and ipsilateral (I) to the
ligation, 7 days after injury.
Samples from mice that underwent L5 ligation showed
higher p62 levels than sham mice (Figure 5A and 5B).
Also, p62 accumulation was marked in the injured side
(I) of SNL animals in comparison to the controlateral
s i d e( C )a n dw a sa b s e n ti ns h a mm i c e( F i g u r e5 Aa n d
5B). As for Beclin 1 and LC3, also p62 accumulation
well correlated with a2δ-1 upregulation in the injured
side of SNL animals and was statistically significant as
shown by statistical analysis of the densitometry data
from 5 SNL mice (*p < 0.05; Figure 5D).
Discussion
Chronic pain is a debilitating condition affecting life
quality and has dramatic economic impact on national
health systems. At present, our ability to treat this con-
dition is limited and there is an urgent need for more
effective treatments. This goal can be achieved through
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Figure 4 Statistical analysis. Quantitative analysis of Western blots
by densitometry confirmed a trend towards an increase in LC3-I (A)
and Beclin 1 (C) expression in the ipsilateral (I) compared to the
controlateral (C) side of SNL animals 7 days after surgery. In the
same animals, this was accompanied by a marked increase in LC3-II
levels (B) and associated to strong a2δ-1 upregulation (D). For LC3-I,
LC3-II, Beclin 1 and a2δ-1: n = 5. Signals from each band were
normalized towards the corresponding GAPDH signal. Values were
expressed as mean ± SEM, * p < 0.05.
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its molecular mechanisms.
Here, we investigated the consequences of nerve injury
on the autophagic process in the spinal cord of mice
that underwent SNL. As previously described [13], a
robust and persistent hypersensitivity to mechanical sti-
mulation developed from the first day following SNL,
lasting up to 28 days. Seven days after injury, a strong
a2δ-1 up-regulation was detectable in the ipsilateral
spinal cord, in line with what has been observed in the
same and other similar neuropathic pain models [15,16].
At this time point, LC3-II was markedly increased in
the L4-L5 spinal cord segment ipsilateral to injury side
in mice that underwent SNL, but it was absent in sham
mice (Figure 2A and 2C). LC3-II formation was paral-
leled by a slight increase in LC3-I expression in the ipsi-
lateral in comparison to the contralateral side (Figure
2A and 2B). LC3-II formation is regarded as a reliable
biochemical evidence of autophagy since the amount of
LC3-II usually correlates well with the number of autop-
hagosomes [20]. However, the accumulation of autopha-
gosomes is not always indicative of autophagy induction
as it may represent either increased generation of autop-
hagosomes and/or a block in autophagosomal matura-
tion and in the completion of the autophagy pathway.
We found that LC3-II formation was associated to a
slightly higher expression of both LC3-I (Figure 2A and
2B) and Beclin 1 (Figure 3A and 3B), suggesting that
autophagy was only mildly induced. On the contrary,
LC3-II accumulation was paralleled by a drastic eleva-
tion of p62 levels (Figure 5A, B and 5D), strongly sup-
porting the hypothesis of a blockade in the autophagic
flux.
It is clear that disruption of the autophagic process in
the CNS is deleterious, resulting in the accumulation of
dysfunctional macromolecules and organelles. Atg5- or
Atg7-deficient mice die within 1 day after birth [21,22],
whereas CNS specific Atg5 or Atg7 knockouts are char-
acterised by growth retardation, motor and behavioral
deficits, extensive neuronal loss and die between 3 and
28 weeks after birth [23,24]. In these mice, the progres-
sion of autophagy disruption was shown to correlate
with neurological dysfunction [24]. Moreover, the autop-
hagic machinery is required for the remodelling of neu-
ronal dendrites and axons and hence for maintaining
CNS plasticity [25]. In neurodegenerative diseases, the
impairment of this last function has been suggested as
the cause for the progressive anatomical and functional
alterations of the CNS occurring when massive cell loss
is still undetectable [25].
The molecular and cellular processes responsible for
the long-lasting abnormal sensory activation underlying
chronic pain are still poorly understood. However, it is
now clear that structural and functional changes in the
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Figure 5 p62 accumulation in the spinal cord following spinal
nerve ligation. (A) p62 expression was analyzed by Western blot in
the hemi-cord contralateral (C) and ipsilateral (I) to the side of
ligation, 7 days after surgery. The minor band detected by the
antibody together with the main upper band has been previously
suggested as a p62 splicing variant or a partially cleaved product
[19]. SNL animals showed higher p62 expression than sham animals
(A). A clear trend towards an increased p62 expression in the
ipsilateral (I) compared to the contralateral (C) side was observed
after ligation (A) and confirmed by densitometric analysis (B). The
increase in p62 levels correlated with a2δ-1 upregulation (A and C)
and was confirmed by quantitative analysis (n = 5, D). Signals from
each band were normalized towards the corresponding GAPDH
signal. Values were expressed as mean ± SEM, * p < 0.05.
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cessing following nerve injury, and contribute to the
development and maintenance of neuropathic pain
states [26]. Although our data do not answer as to
whether autophagy disruption is an epiphenomenon or
whether it is a critical event in pain processing, they
provide a novel observation and open a new line for
further investigations.
Basal and optimally induced levels of autophagy are
particularly critical for neurons. Here, impaired autop-
hagy can be deleterious not only by failing to provide
energy for essential cell functions but also by allowing
accumulation of damaged cellular components and dys-
functional proteins, as well as impairing receptors traf-
ficking and degradation [27], thus affecting neuronal
activity. Interestingly, a key regulator of autophagy is the
growth regulating kinase mTOR. It has been speculated
that, in the adult brain, the regulation at synapses of
both autophagy and protein synthesis by mTOR activity
is critical for different aspects of synaptic plasticity and
that mTOR might act as a critical switch point that sup-
presses autophagy during synaptic strengthening (LTP)
and induces it during LTD [27]. Recently, the mTOR
signalling pathway has been implicated in the regulation
of pain sensitivity [28]. Also, spinal mTOR inhibition by
rapamycin has been shown to profoundly reduce pain
sensitivity in the spared nerve injury (SNI) model of
chronic pain [29], as well as to reduce formalin-induced
pain-related behaviour [30]. Although these effects have
exclusively been ascribed to rapamycin ability to block
protein synthesis, also induction of autophagy may be a
consequence of mTOR inhibition [31]. Therefore,
further experiments will be needed to identify the corre-
lation between the mTOR pathway and the block of
autophagy observed in our model.
Although stronger on the side of injury, an increase in
the autophagic markers was detected also in the contro-
lateral cord, when compared to sham animals (Figure
2A, 3A and 5A). This may reflect an effect also on non-
neuronal cells. In the spinal cord, Beclin 1 and LC3
upregulation have been recently reported after hemi-
transection in both neurons and glial cells [32,33].
Although our data support the occurrence of a block in
autophagosome processing, it is not clear at what late
“digestive” step of the autophagy pathway this may
occur. Autophagy dysfunction associated with autopha-
gosomes accumulation in neurons has been linked to
impaired vesicular transport [34], defective fusion of
autophagosomes with lysosomes [35], or reduced lysoso-
mal activity [36]. In particular, the actions of one or
more cathepsins is essential for degrading autophago-
some cargoes as shown by the autophagy failure and
progressive neurodegeneration observed in cathepsin D
as well as cathepsin B and L knockout mice [37]. In the
light of the growing awareness on the role of glia in
pain processing, further experiments are needed to
investigate the role of autophagy in the different cell
types.
In conclusion, our data showed that autophagy is dis-
rupted in the spinal cord of mice that underwent SNL
and suggest that accumulation of autophagy markers is
likely to result from a block in completion of basal
autophagy rather than up-regulation of the pathway.
To our knowledge, this is the first work reporting an
impairment of spinal autophagy in a model of neuro-
pathic pain and provides a platform for future studies
on the role of this degradative pathway in pain
processing.
Material and methods
Animals
Male C57BL/6 mice (20-22 g) (Charles River, Italy) were
housed in temperature (22° C) and humidity (65%) con-
trolled conditions and subjected to a 12-hour light/dark
cycle (lights on at 8:00am), with free access to water
and pelleted food (VRF1; Charles River, Italy). All the
experimental protocols were in accordance to the guide-
lines of the Italian Ministry of Health for animal care
(D.M. 116/1992).
Surgery
Under 2% isoflurane anaesthesia, a midline incision was
made in the skin of the back at the L2-S2 levels and the
left paraspinal muscles separated from the spinal pro-
cesses at the L4-S1 levels. The L6 transverse process was
carefully removed and the left L5 spinal nerve was iso-
lated and tightly ligated with 6-0 silk thread [11]. Com-
plete hemostasis was confirmed and the wound was
sutured.
The surgical procedure for sham group was identical
to SNL group, except that the spinal nerve was not
ligated. After surgery, foot posture and general mice
behaviour were monitored throughout the postoperative
period. Behavioural testing was carried out over a 4
weeks period.
Behavioural test
Mice were acclimatized in the test chambers for at least
1 h until the exploratory activity had ceased. The beha-
vioural tests were performed twice daily 3 and 5 days
before surgery (baseline) and then 1, 3, 7, 10, 14, 17, 21,
24 and 28 days after spinal nerve ligation. Mechanical
sensitivity was evaluated by Von Frey test [11,13]. The
threshold was determined by using the up-down method
as previously described [13,38] and data were expressed
as mean of the 50% pain threshold ± SEM.
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Mice were killed 7 days after surgery and the spinal
lumbar segment (L4-L5) rapidly removed. The ipsi- and
contra-lateral sides of each spinal cord were dissected,
snap-frozen and stored at -80°C until further processing.
For protein extraction, each single hemi-cord segment
was homogenized in ice-cold lysis buffer (50 mM Tris-
HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0,1% SDS,
1% IGEPAL, 0,5% Na-deoxycholate) in the presence of
protease inhibitors (cod. P8349; Sigma-Aldrich, Milan,
Italy) and incubated on ice for 40 min. Samples were
then centrifuged at 14,000 × g for 15 min at 4 °C. Total
protein content was determined in the supernatants by
the Bio-Rad DC Protein Assay Kit (Bio-Rad Labora-
tories, Milan, Italy). For Western blot analysis, equal
amount of total proteins were separated by sodium
dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-
PAGE; 15%) and transferred onto PVDF membranes
(Immobilon-P, Sigma-Aldrich, Milan, Italy). After block-
ing for 1 hour at room temperature in Tris-buffered sal-
ine containing 0.05% Tween 20 (TBST) and 5% non-fat
milk, the membranes were incubated overnight at 4°C
with the primary antibody directed against the protein
of interest. After several washes, an appropriate HRP-
conjugated secondary antibody (goat IgG; Pierce Bio-
technology, Rockford, IL, USA) was applied for 1 hour
at room temperature. Peroxidase activity was visualised
using the ECL Western Blotting Detection kit (ECL,
Amersham Biosciences, GE Healthcare, Milan, Italy) and
X-ray films (Hyperfilm ECL, Amersham Bioscience). Sig-
nal intensity was measured using ImageJ software (NIH,
Bethesda, MD, USA). For quantitative analysis, the
Beclin 1, LC3-I, LC3-II, p62 and a2δ-1 signals of each
sample were normalized versus the corresponding
GAPDH signal. Changes in signal intensity were then
expressed as fold increase of the ipsilateral versus the
contralateral side for each individual animal.
The following primary antibodies and dilutions were
used: anti-LC3 1:1000 (cod. PD036; MBL, Japan), anti-
Beclin 1 1:4000 (cod. PD017; MBL, Japan), anti-p62/
SQSTM1 1:1000 (cod. PM045; MBL, Japan), anti-a2δ-1
1:1000 (cod. D219; Sigma-Aldrich, Milan, Italy), anti-
GAPDH 1:40000 (Applied Biosystem, Carlsband, CA, USA).
Statistical analysis
Data were presented as mean ± SEM and statistically
assessed either by two-way ANOVA (behavioral test) or
by Student’s t-test (Western blots). A value of p ≤ 0.05
was considered statistically significant. Calculations were
done using GraphPad Prism (GraphPad Software, Inc).
List of abbreviations
Atg: autophagy-related genes; CNS: central nervous system; LC3:
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rapamycin; LTP: long-term potentiation; LTD: long-term depression; SNI:
spared nerve injury; SNL: spinal nerve ligation; SQSTM1: sequestosome-1
Acknowledgements
This work was supported by the Italian Ministry of Health (ex art 56/2005-PS
05.15). We thank Mr Guido Fico for expert technical assistance.
Author details
1Department of Health Sciences, University “Magna Græcia” of Catanzaro,
88100 Catanzaro, Italy.
2Department of Pharmacobiology and University
Center for Adaptive Disorders and Headache (UCHAD), Section of
Neuropharmacology of Normal and Pathological Neuronal Plasticity,
University of Calabria, 87036 Arcavacata di Rende, Italy.
Authors’ contributions
LB designed the experiments, analysed the data and wrote the manuscript,
RR participated in the design of the experiments and in the analysis of the
data, MM carried out the Western blots, AL carried out the behavioural
study, GB conceived the study, MTC supervised experiments and corrected
the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 19 April 2011 Accepted: 24 October 2011
Published: 24 October 2011
References
1. IASP Task Force on Taxonomy: Part III: Pain Terms, A Current List with
Definitions and Notes on Usage. In Classification of Chronic Pain, Second
Edition Edited by: H. Merskey NB. Seattle 1994, 209-214.
2. Ji RR, Kohno T, Moore KA, Woolf CJ: Central sensitization and LTP: do pain
and memory share similar mechanisms? Trends Neurosci 2003, 26:696-705.
3. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA,
Decosterd I, Coggeshall RE, Woolf CJ: Blocking caspase activity prevents
transsynaptic neuronal apoptosis and the loss of inhibition in lamina II
of the dorsal horn after peripheral nerve injury. J Neurosci 2005,
25:7317-7323.
4. Polgar E, Hughes DI, Arham AZ, Todd AJ: Loss of neurons from laminas I-
III of the spinal dorsal horn is not required for development of tactile
allodynia in the spared nerve injury model of neuropathic pain. J
Neurosci 2005, 25:6658-6666.
5. Levine B, Kroemer G: Autophagy in the pathogenesis of disease. Cell
2008, 132:27-42.
6. Mizushima N, Levine B, Cuervo AM, Klionsky DJ: Autophagy fights disease
through cellular self-digestion. Nature 2008, 451:1069-1075.
7. Mizushima N, Yoshimori T, Levine B: Methods in mammalian autophagy
research. Cell 2010, 140:313-326.
8. Vellai T, Takacs-Vellai K, Sass M, Klionsky DJ: The regulation of aging: does
autophagy underlie longevity? Trends Cell Biol 2009, 19:487-494.
9. He C, Klionsky DJ: Regulation mechanisms and signaling pathways of
autophagy. Annu Rev Genet 2009, 43:67-93.
10. Nixon RA, Yang DS, Lee JH: Neurodegenerative lysosomal disorders: a
continuum from development to late age. Autophagy 2008, 4:590-599.
11. Kim SH, Chung JM: An experimental model for peripheral neuropathy
produced by segmental spinal nerve ligation in the rat. Pain 1992,
50:355-363.
12. Liu CN, Wall PD, Ben-Dor E, Michaelis M, Amir R, Devor M: Tactile allodynia
in the absence of C-fiber activation: altered firing properties of DRG
neurons following spinal nerve injury. Pain 2000, 85:503-521.
13. Berliocchi L, Russo R, Levato A, Fratto V, Bagetta G, Sakurada S, Sakurada T,
Mercuri NB, Corasaniti MT: (-)-Linalool attenuates allodynia in neuropathic
pain induced by spinal nerve ligation in c57/bl6 mice. Int Rev Neurobiol
2009, 85:221-235.
14. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH,
Bazan NG, Blagosklonny MV, Blomgren K, Borner C, et al: Guidelines for the
use and interpretation of assays for monitoring cell death in higher
eukaryotes. Cell Death Differ 2009, 16:1093-1107.
15. Bauer CS, Nieto-Rostro M, Rahman W, Tran-Van-Minh A, Ferron L, Douglas L,
Kadurin I, Sri Ranjan Y, Fernandez-Alacid L, Millar NS, et al: The increased
trafficking of the calcium channel subunit alpha2delta-1 to presynaptic
Berliocchi et al. Molecular Pain 2011, 7:83
http://www.molecularpain.com/content/7/1/83
Page 7 of 8terminals in neuropathic pain is inhibited by the alpha2delta ligand
pregabalin. J Neurosci 2009, 29:4076-4088.
16. Li CY, Song YH, Higuera ES, Luo ZD: Spinal dorsal horn calcium channel
alpha2delta-1 subunit upregulation contributes to peripheral nerve
injury-induced tactile allodynia. J Neurosci 2004, 24:8494-8499.
17. Korolchuk VI, Menzies FM, Rubinsztein DC: A novel link between
autophagy and the ubiquitin-proteasome system. Autophagy 2009,
5:862-863.
18. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A,
Stenmark H, Johansen T: p62/SQSTM1 forms protein aggregates
degraded by autophagy and has a protective effect on huntingtin-
induced cell death. J Cell Biol 2005, 171:603-614.
19. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N,
Iwata J, Ezaki J, Murata S, et al: Homeostatic levels of p62 control
cytoplasmic inclusion body formation in autophagy-deficient mice. Cell
2007, 131:1149-1163.
20. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T,
Kominami E, Ohsumi Y, Yoshimori T: LC3, a mammalian homologue of
yeast Apg8p, is localized in autophagosome membranes after
processing. Embo J 2000, 19:5720-5728.
21. Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T,
Ohsumi Y, Tokuhisa T, Mizushima N: The role of autophagy during the
early neonatal starvation period. Nature 2004, 432:1032-1036.
22. Komatsu M, Waguri S, Ueno T, Iwata J, Murata S, Tanida I, Ezaki J,
Mizushima N, Ohsumi Y, Uchiyama Y, et al: Impairment of starvation-
induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol
2005, 169:425-434.
23. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-
Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N:
Suppression of basal autophagy in neural cells causes
neurodegenerative disease in mice. Nature 2006, 441:885-889.
24. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M,
Uchiyama Y, Kominami E, Tanaka K: Loss of autophagy in the central
nervous system causes neurodegeneration in mice. Nature 2006,
441:880-884.
25. Marino G, Madeo F, Kroemer G: Autophagy for tissue homeostasis and
neuroprotection. Curr Opin Cell Biol 2010.
26. Sandkuhler J: Models and mechanisms of hyperalgesia and allodynia.
Physiol Rev 2009, 89:707-758.
27. Boland B, Nixon RA: Neuronal macroautophagy: from development to
degeneration. Mol Aspects Med 2006, 27:503-519.
28. Jimenez-Diaz L, Geranton SM, Passmore GM, Leith JL, Fisher AS, Berliocchi L,
Sivasubramaniam AK, Sheasby A, Lumb BM, Hunt SP: Local translation in
primary afferent fibers regulates nociception. PLoS One 2008, 3:e1961.
29. Geranton SM, Jimenez-Diaz L, Torsney C, Tochiki KK, Stuart SA, Leith JL,
Lumb BM, Hunt SP: A rapamycin-sensitive signaling pathway is essential
for the full expression of persistent pain states. J Neurosci 2009,
29:15017-15027.
30. Asante CO, Wallace VC, Dickenson AH: Mammalian target of rapamycin
signaling in the spinal cord is required for neuronal plasticity and
behavioral hypersensitivity associated with neuropathy in the rat. J Pain
2010, 11:1356-1367.
31. Klionsky DJ, Emr SD: Autophagy as a regulated pathway of cellular
degradation. Science 2000, 290:1717-1721.
32. Kanno H, Ozawa H, Sekiguchi A, Itoi E: Spinal cord injury induces
upregulation of Beclin 1 and promotes autophagic cell death. Neurobiol
Dis 2009, 33:143-148.
33. Kanno H, Ozawa H, Sekiguchi A, Yamaya S, Itoi E: Induction of Autophagy
and Autophagic Cell Death in Damaged Neural Tissue after Acute Spinal
Cord Injury in Mice. Spine (Phila Pa 1976) 2011, 36:1427-1434.
34. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL,
Raman R, Davies P, Masliah E, Williams DS, Goldstein LS: Axonopathy and
transport deficits early in the pathogenesis of Alzheimer’s disease.
Science 2005, 307:1282-1288.
35. Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, O’Kane CJ,
Brown SD, Rubinsztein DC: Dynein mutations impair autophagic
clearance of aggregate-prone proteins. Nat Genet 2005, 37:771-776.
36. Bi X, Zhou J, Lynch G: Lysosomal protease inhibitors induce
meganeurites and tangle-like structures in entorhinohippocampal
regions vulnerable to Alzheimer’s disease. Exp Neurol 1999, 158:312-327.
37. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T,
Peters C, von Figura K, Mizushima N, et al: Participation of autophagy in
storage of lysosomes in neurons from mouse models of neuronal
ceroid-lipofuscinoses (Batten disease). Am J Pathol 2005, 167:1713-1728.
38. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative
assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994,
53:55-63.
doi:10.1186/1744-8069-7-83
Cite this article as: Berliocchi et al.: Autophagy impairment in a mouse
model of neuropathic pain. Molecular Pain 2011 7:83.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Berliocchi et al. Molecular Pain 2011, 7:83
http://www.molecularpain.com/content/7/1/83
Page 8 of 8